2025年全球治疗性血浆置换市场报告

预计未来几年治疗性血浆置换市场规模将强劲成长。到 2029 年，这一数字将成长至 23.2 亿美元，复合年增长率为 9.5%。预测期内的增长可归因于老年人口、临床证据和指南、法规环境、医院基础设施和医疗保健投资、医疗保健支出和报销政策的增加。预测期内的主要趋势包括个人化护理、自动化整合、协作倡议和远端医疗整合。

预计血液疾病盛行率的不断上升将推动未来治疗性血浆置换市场的扩张。血液疾病（血液疾病）包括影响血液和造血组织（如骨髓、淋巴结和脾臟）的疾病。这些疾病的增加是由于遗传倾向、环境影响和生活方式改变等因素所造成的。治疗性血浆置换 (TPE) 用于治疗血液疾病，透过去除血浆中的致病物质，例如自体免疫溶血性贫血中的自身抗体和血栓性血小板低下紫斑症中的免疫复合物，从而减轻疾病的严重程度并改善患者的预后。例如，2023年8月，美国专业组织白血病和淋巴瘤协会预测，从2021年到2023年，骨髓瘤诊断数量将增加约2.3%，分别从34,920例增加到35,730例。因此，血液疾病的高盛行率正在推动治疗性血浆置换市场的成长。

2022年7月，美国科技公司Terumo Corporation Blood and Cell Technologies与专门从事用于治疗发炎和肾臟相关疾病的血液分离术的美国医疗器材公司Areas 医疗设备建立策略伙伴关係。此次合作的重点是透过选择性地从血浆中去除发炎蛋白 Gal-3 来解决急性肾损伤 (AKI) 和脓毒症引起的 AKI (S-AKI)。此次合作旨在利用Terumo Corporation的 Spectra Optia 单采系统和 Eliaz Therapeutics 的 XGal-3管柱探索新型疗法。鑑于 AKI 的高死亡率，此次伙伴关係的初步研究将在大型动物身上进行，然后再进行人体临床试验。 Terumo Corporation以其在治疗性血液分离方面的专业知识而闻名，此前曾合作开展针对三阴性乳癌和 COVID-19 等疾病的计划。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球治疗性血浆置换PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球治疗性血浆置换市场：成长率分析
• 全球治疗性血浆置换市场表现：规模与成长，2019-2024
• 全球治疗性血浆置换市场预测：规模与成长，2024-2029 年，2034 年
• 全球治疗性血浆置换总目标市场（TAM）

第六章市场区隔

• 全球治疗性血浆置换市场类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
• 治疗性血浆置换（TPE）
• 双重过滤血浆置换术（DFPP）
• 全球治疗性血浆置换市场（依适应症、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 神经系统疾病
• 血液系统疾病
• 肾臟疾病
• 代谢紊乱
• 其他适应症
• 全球治疗性血浆置换市场（依技术、绩效及预测），2019-2024 年、2024-2029 年及 2034 年
• 离心
• 膜分离
• 全球治疗性血浆置换市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年及 2034 年
• 血液采集中心
• 医院和诊所
• 输血中心
• 其他最终用户
• 全球治疗性血浆置换市场、治疗性血浆置换 (TPE) 细分市场、按类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 手动TPE
• 自动化TPE
• 全球治疗性血浆置换市场双滤血浆置换（DFPP）类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 单级DFPP
• 多阶段DFPP

第七章 区域和国家分析

• 全球治疗性血浆置换市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球治疗性血浆置换市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 治疗性血浆置换市场：竞争格局
• 治疗性血浆置换市场：公司简介
  • Medica SpA Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
  • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Baxter International Inc.
• B Braun Melsungen AG
• Terumo Corporation
• Kaneka Corporation
• Charles River Laboratories
• Octapharma AG
• Spectral Medical Inc.
• Nikkiso Co. Ltd.
• Haemonetics Corporation
• Miltenyi Biotec Technology And Trading Co. Ltd.
• Macopharma SA
• Cerus Corporation
• Apellis Pharmaceuticals Inc.
• ImmunoTek Bio Centers LLC
• CytoSorbents Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029年治疗性血浆置换市场：提供新机会的国家
• 2029年治疗性血浆置换市场：细分领域带来新机会
• 2029年治疗性血浆置换市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Therapeutic plasma exchange (TPE) is a medical intervention utilized in the treatment of specific autoimmune diseases and other medical conditions. In this procedure, blood is extracted from the body, the plasma component (the fluid part of blood) is separated from the blood cells, and the blood cells are subsequently reintroduced into the body, often after being mixed with a replacement fluid. This method aids in eliminating harmful substances from the bloodstream, such as autoantibodies or toxins, which are implicated in various diseases.

The primary modalities of therapeutic plasma exchange include therapeutic plasma exchange (TPE) and double-filtered plasmapheresis (DFPP). Therapeutic Plasma Exchange (TPE) is a clinical process that involves removing plasma from the blood and substituting it with a replacement fluid, facilitating the elimination of detrimental substances or excess components. This procedure finds application in diverse medical conditions such as neurological disorders, hematological disorders, renal disorders, metabolic disorders, among others. Various technologies, including centrifugation and membrane separation, are employed in this process, catering to a range of end users such as blood collection centers, hospitals and clinics, transfusion centers, and others.

The therapeutic plasma exchange market research report is one of a series of new reports from The Business Research Company that provides therapeutic plasma exchange market statistics, including therapeutic plasma exchange industry global market size, regional shares, competitors with a therapeutic plasma exchange market share, detailed therapeutic plasma exchange market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic plasma exchange industry. This therapeutic plasma exchange market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The therapeutic plasma exchange market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to the emergence of immunological diseases, increasing technological advancements, increased awareness and education, expanded indications, and improved understanding of the pathophysiology.

The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the rising geriatric population, clinical evidence and guidelines, regulatory environment, hospital infrastructure and healthcare investments, healthcare expenditure, and reimbursement policies. Major trends in the forecast period include personalized therapies, integration of automation, collaborative initiatives, and telemedicine integration.

The increasing prevalence of hematological disorders is poised to drive the expansion of the therapeutic plasma exchange market in the future. Hematological disorders, or blood disorders, encompass medical conditions affecting blood and blood-forming tissues such as bone marrow, lymph nodes, and spleen. The rise in these disorders is attributed to factors such as genetic predispositions, environmental influences, and changes in lifestyle. Therapeutic plasma exchange (TPE) is employed in managing hematological disorders by removing pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thus alleviating disease severity and enhancing patient outcomes. For example, in August 2023, as per the Leukemia and Lymphoma Society, a US-based professional organization, the projected number of myeloma diagnoses is expected to increase by approximately 2.3% from 2021 to 2023, rising from 34,920 to 35,730, respectively. Hence, the high prevalence of hematological disorders is fueling the growth of the therapeutic plasma exchange market.

In July 2022, Terumo Blood and Cell Technologies, a US-based technology company, formed a strategic partnership with Eliaz Therapeutics Inc., a US-based medical device company specializing in therapeutic apheresis for inflammatory and kidney-related conditions. This collaboration focuses on addressing acute kidney injury (AKI) and sepsis-induced AKI (S-AKI) by selectively removing the inflammatory protein Gal-3 from blood plasma. The partnership aims to explore novel treatments using Terumo's Spectra Optia Apheresis System and Eliaz Therapeutics' XGal-3 column. Given the high mortality rates associated with AKI, the partnership's initial studies will be conducted in large animals before progressing to human clinical trials. Terumo is known for its expertise in therapeutic apheresis and has previously collaborated on projects targeting conditions such as triple-negative breast cancer and COVID-19.

In July 2022, Discovery Life Sciences, Inc., a US-based provider of biospecimen analysis services, acquired AllCells for an undisclosed amount. This strategic acquisition aims to create a leading global provider of critical starting materials and analytic services, enhancing the development of cell and gene therapies (CGT) across the entire continuum-from discovery to commercialization. AllCells, a US-based company, specializes in providing clinical-grade and research-use primary cell products, including plasma exchange or plasmapheresis services. The acquisition is expected to strengthen Discovery Life Sciences' capabilities in supporting CGT development, positioning the company as a key player in the biotechnology and healthcare sectors.

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.

North America was the largest region in the therapeutic plasma exchange market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the therapeutic plasma exchange market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic plasma exchange market consists of revenues earned by entities by providing services such as patient evaluation, treatment planning, medical monitoring, and plasma separation. The market value includes the value of related goods sold by the service provider or included within the service offering. The therapeutic plasma exchange market also includes the sale of plasma separators, replacement fluids, anticoagulants, catheters and access devices, disposable consumables, and monitoring equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Therapeutic Plasma Exchange Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on therapeutic plasma exchange market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic plasma exchange ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The therapeutic plasma exchange market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Therapeutic Plasma Exchange (TPE); Double Filtered Plasmapheresis (DFPP)
• 2) By Indication: Neurological Disorders; Hematological Disorders; Renal Disorders; Metabolic Disorders; Other Indications
• 3) By Technology: Centrifugation; Membrane Separation
• 4) By End User: Blood Collection Centers; Hospitals And Clinics; Transfusion Centers; Other End Users
• Subsegments:
• 1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe; Automated Tpe
• 2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp; Multi-Stage Dfpp
• Companies Mentioned: Medica S.p.A.; Fresenius SE and Co. KGaA; Medtronic Plc.; Asahi Kasei Corporation; Toray Industries Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Therapeutic Plasma Exchange Market Characteristics

3. Therapeutic Plasma Exchange Market Trends And Strategies

4. Therapeutic Plasma Exchange Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Therapeutic Plasma Exchange Growth Analysis And Strategic Analysis Framework

• 5.1. Global Therapeutic Plasma Exchange PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Therapeutic Plasma Exchange Market Growth Rate Analysis
• 5.4. Global Therapeutic Plasma Exchange Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Therapeutic Plasma Exchange Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Therapeutic Plasma Exchange Total Addressable Market (TAM)

6. Therapeutic Plasma Exchange Market Segmentation

• 6.1. Global Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Plasma Exchange (TPE)
• Double Filtered Plasmapheresis (DFPP)
• 6.2. Global Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurological Disorders
• Hematological Disorders
• Renal Disorders
• Metabolic Disorders
• Other Indications
• 6.3. Global Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centrifugation
• Membrane Separation
• 6.4. Global Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Collection Centers
• Hospitals And Clinics
• Transfusion Centers
• Other End Users
• 6.5. Global Therapeutic Plasma Exchange Market, Sub-Segmentation Of Therapeutic Plasma Exchange (TPE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manual TPE
• Automated TPE
• 6.6. Global Therapeutic Plasma Exchange Market, Sub-Segmentation Of Double Filtered Plasmapheresis (DFPP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Stage DFPP
• Multi-Stage DFPP

7. Therapeutic Plasma Exchange Market Regional And Country Analysis

• 7.1. Global Therapeutic Plasma Exchange Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Therapeutic Plasma Exchange Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Therapeutic Plasma Exchange Market

• 8.1. Asia-Pacific Therapeutic Plasma Exchange Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Therapeutic Plasma Exchange Market

• 9.1. China Therapeutic Plasma Exchange Market Overview
• 9.2. China Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Therapeutic Plasma Exchange Market

• 10.1. India Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Therapeutic Plasma Exchange Market

• 11.1. Japan Therapeutic Plasma Exchange Market Overview
• 11.2. Japan Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Therapeutic Plasma Exchange Market

• 12.1. Australia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Therapeutic Plasma Exchange Market

• 13.1. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Therapeutic Plasma Exchange Market

• 14.1. South Korea Therapeutic Plasma Exchange Market Overview
• 14.2. South Korea Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Therapeutic Plasma Exchange Market

• 15.1. Western Europe Therapeutic Plasma Exchange Market Overview
• 15.2. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Therapeutic Plasma Exchange Market

• 16.1. UK Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Therapeutic Plasma Exchange Market

• 17.1. Germany Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Therapeutic Plasma Exchange Market

• 18.1. France Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Therapeutic Plasma Exchange Market

• 19.1. Italy Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Therapeutic Plasma Exchange Market

• 20.1. Spain Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Therapeutic Plasma Exchange Market

• 21.1. Eastern Europe Therapeutic Plasma Exchange Market Overview
• 21.2. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Therapeutic Plasma Exchange Market

• 22.1. Russia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Therapeutic Plasma Exchange Market

• 23.1. North America Therapeutic Plasma Exchange Market Overview
• 23.2. North America Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Therapeutic Plasma Exchange Market

• 24.1. USA Therapeutic Plasma Exchange Market Overview
• 24.2. USA Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Therapeutic Plasma Exchange Market

• 25.1. Canada Therapeutic Plasma Exchange Market Overview
• 25.2. Canada Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Therapeutic Plasma Exchange Market

• 26.1. South America Therapeutic Plasma Exchange Market Overview
• 26.2. South America Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Therapeutic Plasma Exchange Market

• 27.1. Brazil Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Therapeutic Plasma Exchange Market

• 28.1. Middle East Therapeutic Plasma Exchange Market Overview
• 28.2. Middle East Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Therapeutic Plasma Exchange Market

• 29.1. Africa Therapeutic Plasma Exchange Market Overview
• 29.2. Africa Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Therapeutic Plasma Exchange Market Competitive Landscape And Company Profiles

• 30.1. Therapeutic Plasma Exchange Market Competitive Landscape
• 30.2. Therapeutic Plasma Exchange Market Company Profiles
  • 30.2.1. Medica S.p.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Therapeutic Plasma Exchange Market Other Major And Innovative Companies

• 31.1. Baxter International Inc.
• 31.2. B Braun Melsungen AG
• 31.3. Terumo Corporation
• 31.4. Kaneka Corporation
• 31.5. Charles River Laboratories
• 31.6. Octapharma AG
• 31.7. Spectral Medical Inc.
• 31.8. Nikkiso Co. Ltd.
• 31.9. Haemonetics Corporation
• 31.10. Miltenyi Biotec Technology And Trading Co. Ltd.
• 31.11. Macopharma SA
• 31.12. Cerus Corporation
• 31.13. Apellis Pharmaceuticals Inc.
• 31.14. ImmunoTek Bio Centers LLC
• 31.15. CytoSorbents Corporation

32. Global Therapeutic Plasma Exchange Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Therapeutic Plasma Exchange Market

34. Recent Developments In The Therapeutic Plasma Exchange Market

35. Therapeutic Plasma Exchange Market High Potential Countries, Segments and Strategies

• 35.1 Therapeutic Plasma Exchange Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Therapeutic Plasma Exchange Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Therapeutic Plasma Exchange Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer